Literature DB >> 8129662

Pars plana vitrectomy for treatment of stage 2 macular holes.

A J Ruby1, D F Williams, M G Grand, M A Thomas, T A Meredith, I Boniuk, R J Olk.   

Abstract

OBJECTIVE: To assess the anatomic outcome and visual acuities at follow-up after pars plana vitrectomy in the management of stage 2 macular holes.
DESIGN: Retrospective.
SETTING: Retina Consultants, Ltd, St Louis, Mo. PATIENTS: Thirty-three patients, aged 43 to 75 years, with stage 2 macular holes. INTERVENTION: Total pars plana vitrectomy with separation of the posterior hyaloid membrane and injection of intraocular gas followed by postoperative face-down positioning. MAIN OUTCOME MEASURES: Visual acuity and anatomic appearance of the macular hole.
RESULTS: Postoperatively, 20 (61%) of 33 eyes attained a visual acuity of 20/50 or greater. Twenty (61%) of 33 eyes showed an improvement in visual acuity, while nine (27%) of 33 were stable. Four (12%) of 33 eyes showed a decline in postoperative visual acuity with progression to a stage 3 macular hole. Twenty-five (76%) of 33 eyes showed stabilization or improvement in the appearance of the macular hole.
CONCLUSIONS: Pars plana vitrectomy in conjunction with postoperative intraocular gas tamponade may result in visual and anatomic stabilization or improvement in eyes with stage 2 macular holes. However, because of limited natural history data, it is unknown whether these results are any better than those that might occur without surgery.

Entities:  

Mesh:

Year:  1994        PMID: 8129662     DOI: 10.1001/archopht.1994.01090150089029

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  14 in total

Review 1.  Idiopathic full thickness macular hole: natural history and pathogenesis.

Authors:  E Ezra
Journal:  Br J Ophthalmol       Date:  2001-01       Impact factor: 4.638

2.  Results of vitrectomy and the no-touch-technique using autologous adjuvants in macular hole treatment.

Authors:  H Hoerauf; H Klüter; E Joachimmeyer; J Roider; C Framme; P Schlenke; H Kirchner; H Lagua
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

3.  [Long-term functional results after macular hole surgery. Results of a prospective study].

Authors:  I W Reiniger; C A Gass; M Schaumberger; A Kampik; C Haritoglou
Journal:  Ophthalmologe       Date:  2006-06       Impact factor: 1.059

4.  Peripheral visual field loss after vitreous surgery for macular holes.

Authors:  S Bopp; K Lucke; U Hille
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

5.  Natural outcomes of stage 1, 2, 3, and 4 idiopathic macular holes.

Authors:  J Ferris
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

6.  Paracentral scotomata: a new finding after vitrectomy for idiopathic macular hole.

Authors:  C Haritoglou; O Ehrt; C A Gass; N Kristin; A Kampik
Journal:  Br J Ophthalmol       Date:  2001-02       Impact factor: 4.638

7.  Comparative evaluation of anatomical and functional outcomes using brilliant blue G versus triamcinolone assisted ILM peeling in macular hole surgery in Indian population.

Authors:  Atul Kumar; Varun Gogia; Vinit M Shah; Tapas C Nag
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-01-14       Impact factor: 3.117

8.  Natural outcomes of stage 1, 2, 3, and 4 idiopathic macular holes.

Authors:  T Hikichi; A Yoshida; J Akiba; C L Trempe
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

Review 9.  Macular holes.

Authors:  T Barrie
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

10.  Autologous platelet concentrate for the treatment of full-thickness macular holes.

Authors:  A Gaudric; P Massin; M Paques; P Y Santiago; J E Guez; J F Le Gargasson; O Mundler; L Drouet
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-09       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.